AbbVie's Telisotuzumab Adizutecan Achieves FDA Breakthrough Designations for Cancer Treatments #United_States #AbbVie #North_Chicago #Telisotuzumab #Temab-A
@newsen.bsky.socialExplore
@newsen.bsky.social
@newsen.bsky.socialAbbVie's Telisotuzumab Adizutecan Achieves FDA Breakthrough Designations for Cancer Treatments #United_States #AbbVie #North_Chicago #Telisotuzumab #Temab-A